cannalin.
Cannabinoid Analysis
Batch 20272151
CBD Liposomal 4%
Independent laboratory analysis · analysis no. #302261
| Tested for | Cannalin | Analysis no. | #302261 |
|---|---|---|---|
| Sample name | CBD Liposomal 4% | Batch code | 20272151 |
| Sample type | Liposomal CBD | Analysis date | 12-10-2026 |
| Laboratory | Canalyse | Valid until | 11-10-2028 |
Cannabinoid composition
CBD 4,33%
CBG 0,90%
CBN 0,56%
CBC 0,11%
CBDV 0,41%
Other 93,69%
Results
| CBD | 4,33 % | Δ8-THC | 0,00 % |
| Δ9-THC | 0,00 % | CBG | 0,90 % |
| CBN | 0,56 % | CBC | 0,11 % |
| CBDV | 0,41 % | THCV | 0,00 % |
| Total cannabinoids | 6,31 % |